Heart failure update: Treatment of heart failure with a normal left ventricular ejection fraction in the elderly

Geriatrics

Volumn 61, Issue 8, 2006, Pages 16-20

  Aronow, Wilbert S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Diastolic disfuntion; Heart failure

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CAPSAICIN; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FUROSEMIDE; HYALURONIC ACID; HYDRALAZINE; HYDROCHLOROTHIAZIDE; ISOSORBIDE DINITRATE; METOPROLOL; NARCOTIC ANALGESIC AGENT; NEBIVOLOL; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PARACETAMOL; PROPRANOLOL; SALICYLIC ACID METHYL ESTER; TRAMADOL; VERAPAMIL;

AGE; ANEMIA; ARTHRITIS; ARTICLE; CLINICAL TRIAL; DEHYDRATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; HYPERTHYROIDISM; HYPOTHYROIDISM; LOW DRUG DOSE; PREVALENCE; RISK FACTOR; SLEEP APNEA SYNDROME; SYSTOLIC HYPERTENSION; UNITED STATES; UREMIA;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALCIUM CHANNEL BLOCKERS; CARDIOTONIC AGENTS; COMORBIDITY; DIGOXIN; DIURETICS; EXERCISE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; MYOCARDIAL REVASCULARIZATION; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 33747607064     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005; 46(6):1116-43. http://www.acc.org/clinical/guidelines/failure/index.pdf. Accessed July 18, 2006.
2. Aronow WS, Ahn C, Kronzon I. Normal left ventricular ejection fraction in older persons with congestive heart failure. Chest 1998; 113(4):867-9.
3. Aronow WS, Ahn C, Kronzon I. Comparison of incidences of congestive heart failure in older African-Americans, Hispanics, and whites. Am J Cardiol 1999; 84(5):611-2.
4. Vasan RS, Larson MG, Benjamin EJ, et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction. J Am Coll Cardiol 1999; 33(7):1948-55.
5. Gottdiener JS, McClelland RL, Marshall R, et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med 2002; 137(8):631-9.
6. Aronow WS. Effects of aging on the heart. In: Tallis RC, Fillit HM (eds). Brocklehurst's Textbook of Geriatric Medicine and Gerontology, 6th ed. Churchill Livingstone, Edinburgh, 2003, pp 341-8.
7. Aronow WS, Ahn C, Kronzon I. Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction ≥40% treated with diuretics plus angiotensin-converting- enzyme inhibitors. Am J Cardiol 1997; 80(2):207-9.
8. Flather MD, Shibata MC, Coats AJS, et al. Randomized trial to determine the effect of nevibolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005; 26(3):215-25.
9. Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology: W. J. Remme and K. Swedberg (Co-Chairmen). Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22(23):1527-60.
10. Aronow WS, Kronzon I. Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction. Am J Cardiol 1993; 71(7):602-4.
11. Philbin EF, Rocco TA Jr, Lindenmuth NW, et al. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med 2000; 109(8):605-13.
12. Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved trial. Lancet 2003; 362(9386):777-81.
13. Conn JN, Johnson G. Heart failure with normal ejection fraction. The V-HeFT Study. Veterans Administration Cooperative Study Group. Circulation 1990; 81(2 suppl):111-48-53.
14. Setaro JF, Zaret BL, Schulman DS, et al. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol 1990; 66(12):981-6.
15. Aronow WS. Echocardiography should be performed in all elderly patients with congestive heart failure. J Am Geriatr Soc 1994; 42(12):1300-2.
16. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336(8);525-33.
17. Rich MW, McSherry F, Williford WO, et al. Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG Study. J Am Coll Cardiol 2001; 38(3):806-13.
18. Ahmed A, Aronow WS, Fleg JL. Predictors of mortality and hospitalization in women with heart failure in the Digitalis Investigation Group trial. Am J Therap 2006; 13:325-31.
19. Ahmed A, Aronow WS, Fleg JL. Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function. Am Heart J 2006; 151(2):444-50.
20. Aronow WS. Exercise therapy for older persons with cardiovascular disease. Am J Geriatr Cardiol 2001; 10(5):245-52.